Taneza, Mishel A.

HRN: 11-39-46  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/31/2024
CEFUROXIME 750MG (VIAL)
07/31/2024
08/07/2024
IV
750mg
Q8
Acute Pyelonephritis
Rejected 

 Indication:  Empiric    Type of Infection:  Urinary Tract    Compliance to guidelines: Non-compliant To Guidelines